Drug Research

Researchers have gone on to demonstrate that microscopic drug delivery containers can get magnetically steered to their objectives, thereby advancing the development when it comes to precision medicine for the treatment of diseases like cancer. A multi-university team, which...

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs...

The UK government will improve manufacturing and commercialisation as it seeks to maximise the value of the life sciences sector growth for the country's economy. In a new Life Sciences sector growth plan, the government established a six-point action plan...

Scientists applied artificial intelligence (AI) to reanalyse a clinical trial for AI in Alzheimer Drug Development, identifying a group of patients who responded to medical treatment. The study shows that AI can help design future clinical trials to be...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety and efficacy of MK-8527, an investigational once-monthly, oral nucleoside reverse transcriptase translocation...

The National Health Commission and China's National Healthcare Security Administration (NHSA) together unveiled a comprehensive new policy on June 30 called "Several Measures to Support the High-Quality Development of Innovative Drugs". The policy, which was formally unveiled to the...

London, 28 June 2025 – In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it will invest $1 billion by 2030 to further expand its US manufacturing and R&D...